Armata Pharmaceuticals, Inc. (ARMP) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
ARMP Revenue Analysis (2013–2024)
As of March 5, 2026, Armata Pharmaceuticals, Inc. (ARMP) generated trailing twelve-month (TTM) revenue of $5.1 million, reflecting significant decline in growth of -61.0% year-over-year. The most recent quarter (Q3 2025) recorded $1.2 million in revenue, down 46.6% sequentially.
Looking at the longer-term picture, ARMP's historical revenue data shows a 3-year CAGR of +5.0%. The company achieved its highest annual revenue of $5.5 million in 2022.
When compared to Healthcare sector peers including EVGN (-26.2% YoY), SYBX (-100.0% YoY), and ELAB (-179.8% YoY), ARMP has underperformed the peer group in terms of revenue growth. Compare ARMP vs EVGN →
Peer Comparison
Compare ARMP's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ARMPCurrent | $5M | -61.0% | - | -820.2% | |
 EVGN | $9M | -26.2% | +62.4% | -255.4% | |
 SYBX | $8,000 | -100.0% | -67.6% | -511875.0% | |
 ELAB | $2M | -179.8% | - | -75.7% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $5.2M | +14.2% | $-29,252,000 | -565.4% | $-42,436,000 | -820.2% |
| 2023 | $4.5M | -17.8% | $3.6M | 78.5% | $-40,890,000 | -902.8% |
| 2022 | $5.5M | +23.1% | $-29,509,000 | -535.7% | $-36,946,000 | -670.8% |
| 2021 | $4.5M | +443.6% | $-15,541,000 | -347.4% | $-23,822,000 | -532.5% |
| 2020 | $823K | - | $-13,621,000 | -1655.0% | $-21,587,000 | -2623.0% |
| 2019 | $0 | - | $-1,351,000 | - | $-19,089,000 | - |
| 2018 | $0 | -100.0% | $-1,351,000 | - | $-12,524,000 | - |
| 2017 | $115K | -55.8% | $-259,000 | -225.2% | $-16,156,000 | -14048.7% |
| 2016 | $260K | -45.3% | $-109,000 | -41.9% | $-23,378,000 | -8991.5% |
| 2015 | $475K | +16.1% | $475K | 100.0% | $-10,227,000 | -2153.1% |
See ARMP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARMP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ARMP vs LLY
See how ARMP stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
Is ARMP's revenue growth accelerating or slowing?
ARMP revenue declined -61.0% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $5M. This reverses the prior growth trend.
What is ARMP's long-term revenue growth rate?
Armata Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -61.0% is below this long-term average.
How is ARMP's revenue distributed by segment?
ARMP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.